TI
LFCR icon

Trexquant Investment’s Lifecore Biomedical LFCR Stock Holding History

Trexquant Investment’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-47,157
Closed -$356K – 1636
2023
Q3 		$356K Buy
+47,157
New +$431K 0.01% 1158
2022
Q1 		– Sell
-12,624
Closed -$140K – 1567
2021
Q4 		$140K Buy
12,624
+1,874
+17% +$18.2K 0.01% 1201
2021
Q3 		$99K Buy
+10,750
New +$117K 0.01% 1053
2021
Q2 		– Sell
-11,239
Closed -$119K – 1319
2021
Q1 		$119K Sell
11,239
-1,867
-14% -$21K 0.01% 1039
2020
Q4 		$142K Buy
+13,106
New +$135K 0.02% 944
2017
Q3 		– Sell
-11,259
Closed -$167K – 915
2017
Q2 		$167K Buy
+11,259
New +$157K 0.05% 700

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Trexquant Investment's LFCR Position: Q4 2023 in Review

Trexquant Investment sold out of Lifecore Biomedical (LFCR) in Q4 2023, closing a stake of 47,157 shares — an estimated $356K sold.

Trexquant Investment first reported a position in LFCR in Q2 2017 and held it in 6 quarters. The position peaked at $356K in Q3 2023. 78 funds tracked by Wall St. Rank hold LFCR as of Q4 2023.

  • Trexquant Investment reported no remaining Lifecore Biomedical position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 47,157 Lifecore Biomedical shares in Q4 2023, an estimated $356K.
  • Trexquant Investment first reported a position in Lifecore Biomedical in Q2 2017 and held it in 6 quarters.
  • Trexquant Investment's Lifecore Biomedical position peaked at $356K in Q3 2023.
  • 78 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.